Migraine aura is a transient, focal neurological phenomenon that predominantly manifests as visual disturbances, paresthesias, or language impairment preceding the headache phase. For decades, aura was attributed to cerebral ischemia caused by vasoconstriction. However, groundbreaking neurophysiological research demonstrated that aura is driven by Cortical Spreading Depression (CSD)—a self-propagating wave of neuronal and glial depolarization across the cerebral cortex. Understanding CSD is critical for understanding how electrical events in the brain translate into painful neurogenic inflammation.
History and Scientific Discovery of CSD
The physiological characterization of CSD evolved through key observations in the 20th century:
Karl Lashley (1941): Psychophysiologist Karl Lashley mapped his own visual aura ("scintillating scotoma"). By calculating the rate at which the visual arc expanded over the 60 mm primary visual cortex, he deduced that a wave of intense cortical excitation traveled across the occipital cortex at approximately $3\text{ mm/min}$.
Aristides Leão (1944): Working with electrocorticography (ECoG) on exposed rabbit cortices, Leão formally identified and named "Spreading Depression". He observed a brief wave of intense neuronal excitation followed by prolonged suppression of electrical activity, propagating precisely at the rate calculated by Lashley ($2\text{--}5\text{ mm/min}$).
Cellular and Electrophysiological Dynamics of CSD
Cortical Spreading Depression is triggered when the homeostatic balance of cortical excitability is disrupted. Local surges in extracellular potassium ions ($[\text{K}^+]$) and glutamate breach a critical threshold, igniting a wave that alters neuronal and glial membrane potentials.
Neurovascular Changes During CSD
CSD causes profound shifts in regional cerebral blood flow (rCBF) that occur independently of classic vascular anatomical boundaries:
Initial Short-Lived Hyperemia: A brief wave of hyperperfusion accompanies the leading edge of neuronal excitation.
Sustained Hypoperfusion: Followed by a prolonged reduction in cortical blood flow (hypoperfusion) that persists for 1 to 2 hours during the phase of neuronal suppression.
Recovery: Blood flow slowly returns to baseline without causing ischemic tissue infarction under physiological conditions.
Mapping Visual Aura: Teichopsia and Retinotopic Anatomy
Visual aura often presents as a fortification spectrum or teichopsia—a expanding zig-zag arc with a scintillating edge and a central blind spot (scotoma). The architecture of this visual illusion directly reflects the anatomical layout of the visual cortex:
The calcarine pole represents the fovea with a large cortical volume; thus, early visual aura near central vision appears small and fine-detailed.
As CSD propagates anteriorly along the primary visual cortex—where less cortical volume represents peripheral vision—the teichopsic arc rapidly expands in radius and arc size as it moves toward the visual periphery.
Because human primary visual cortex spans approximately $60\text{ mm}$, CSD traveling at $3\text{ mm/min}$ takes roughly 20 minutes to traverse the structure, matching the typical 20-to-30 minute duration of clinical visual aura.
How CSD Triggers the Painful Headache Phase
A critical neurobiological question is how a purely cortical electrical event initiates physical headache pain. Research demonstrates that CSD acts as an endogenous trigger for trigeminal pain pathways through several concurrent mechanisms:
Efflux of Noxious Molecules: The passing CSD wavefront releases high concentrations of potassium ($\text{K}^+$), hydrogen ions ($\text{H}^+$), nitric oxide ($\text{NO}$), and arachidonic acid into the cortical extracellular space.
Diffusion to Dural Nociceptors: These chemical mediators diffuse through the pial layer to activate the unmyelinated $C$-fiber terminals of the ophthalmic division ($V_1$) of the trigeminal nerve innervating meningeal blood vessels.
Protease Activation: CSD stimulates matrix metalloproteinases (specifically MMP-9), inducing transient blood-brain barrier leakage that exposes perivascular nerve endings to inflammatory proteins.
Trigeminal Activation: Activation of perivascular nerve endings sends orthodromic nociceptive volleys to the trigeminocervical complex (TCC), initiating the headache phase.